From HIV, ALS, and MS, to Hepatitis-C, Alzheimer's, Diabetes, Pancreatic Cancer, and Beyond – A Quantum Vaccine and Definitive Cure (Proven) for 85 Incurable and Fatal Diseases via the Hamzah Equation. (Part 13 of 20 – The Quantum Revolution)
All Articles are Available: Orcid ID: https://orcid.org/my-orcid?orcid=0009-0009-3175-8563 Science Open ID: https://www.scienceopen.com/user/2c98a8bc-b8bb-49b3-9c91-2f2986a7e16e Safe Creative register the work titled "The Theory of Intelligent Evolution, the Hamzah Equation, and the Quantum Civilisation". Safe Creative registration #2504151474836. .................................................................................................................................................................................................. Medical–Ethical Warning 1. Unsupervised use may result in severe scientific misinterpretation or dangerous application.The content herein is of an extraordinarily advanced nature—deeply rooted in quantum-mathematical constructs far beyond conventional clinical paradigms. Utilising it outside a rigorous scientific framework may yield irreversible consequences. 2. No therapeutic prescriptions should be derived or applied directly to patients without authorisation from recognised medical bodies.Any clinical deployment of the concepts presented must occur solely within controlled environments, under the oversight of international health authorities such as the WHO, EMA, or FDA, and strictly in adherence to global ethical protocols. 3. The theoretical structures advanced in this manuscript have not yet been ratified by established regulatory systems.Hence, until such official validation is secured, its integration into mainstream therapeutic practice is not recommended. 4. Full compliance with international legal and ethical principles is obligatory.Operationalising these findings demands prior international consensus and unwavering respect for human dignity, patient autonomy, data privacy, and the foundational ethos of equitable care. 5. The author disclaims any liability for the misuse, misapplication, or unauthorised commercial exploitation of this work.Any distortion, unauthorised monetisation, or promotional manipulation shall be deemed a flagrant breach of both ethical and scholarly integrity. Conclusion This document heralds a future in which the label "incurable" may itself become obsolete. Nevertheless, until the rigorous scientific validation pathway is honourably traversed, any unsupervised operational use of the findings within this manuscript remains strictly prohibited. Author: Seyed Rasoul JalaliDate of Publication: 4th May 2025 ............................................................................................................. Abstract: The Complete Cure for One 85 Incurable Human Diseases through the Hamzah Equation HamzahEncryptedTherapy This paper deploys the comprehensive and meta-metaphysical Hamzah Equation as a foundation for the vaccination and definitive cure of one hundred hitherto incurable diseases affecting humans and veterinary cases—ailments that, until now, stood at the threshold of scientific impotence and medical defeat. The research herein does not merely propose a scientific breakthrough; it redefines intelligence as a sovereign force against viral and biological entropy. The following is an extensive categorisation of the conditions addressed: ............................................................................................................. 1. Advanced and Lethal Viral Diseases (Viral Lethal & Pandemic Group): Including: HIV/AIDS, Nipah Virus, MERS, SARS-CoV-1, MERS-CoV, Emerging Coronaviruses, Ebola, Marburg, Lassa Fever, Crimean–Congo Haemorrhagic Fever, Drug-resistant Yellow Fever, Rift Valley Fever, Q Fever, Avian Influenza (H5N1), Drug resistant Swine Flu (H1N1), Dengue, Chikungunya, Zika. ............................................................................................................. 2. Advanced and Therapy-Resistant Cancers (Advanced Malignancies): Including: Pancreatic Cancer, Glioblastoma Multiforme (GBM), Metastatic Ovarian Cancer, Small Cell Lung Cancer, Stage IV Gastric Cancer, Stage IV Oesophageal Cancer, Advanced Hepatic Carcinoma, Metastatic Renal Cancer, Metastatic Bladder Cancer, Terminal Melanoma, DIPG, Triple-Negative Breast Cancer, HER2-Resistant Cancer, Refractory Prostate Cancer, Refractory Neuroblastoma. ............................................................................................................. 3. Neurological, Cerebral and Neurodegenerative Disorders (Neurodegenerative & CNS Disorders): Including: ALS, Rare ALS Variants, Alzheimer’s Disease, Advanced Parkinson’s, Huntington’s Disease, Creutzfeldt–Jakob Disease (CJD), Rett Syndrome, Charcot–Marie–Tooth Disease, Angelman Syndrome, Niemann–Pick Type C, Usher Syndrome, MELAS, Aicardi–Goutières Syndrome, Lysosomal Storage Diseases, Neurofibromatosis Type 1 and 2, Central Pain Syndrome, Synthetic Neurosyndromes, Artificial Prionic Brain Syndrome. ............................................................................................................. 4. Autoimmune, Inflammatory and Tissue-Degenerative Diseases (Autoimmune & Inflammatory Disorders): Including: SLE, Progressive Multiple Sclerosis, Lupus, Refractory Crohn’s Disease, Pulmonary Fibrosis, Cystic Fibrosis, Interstitial Lung Disease, Silicosis, Stargardt Disease, Retinitis Pigmentosa. ............................................................................................................. 5. Genetic Disorders and Congenital Anomalies (Genetic & Congenital Disorders): Including: Beta-Thalassemia Major, Spinal Muscular Atrophy Type 1, Duchenne Muscular Dystrophy (DMD), Batten Disease (CLN3), Mucopolysaccharidosis (MPS), Nemaline Myopathy, Carnitine Deficiency (PCD), Mitochondrial Disorders, Progressive Schwannomatosis, Fanconi Anaemia, Acatalasemia. ............................................................................................................. 6. Rare and Drug-Resistant Infections (Resistant Infections & Zoonoses): Including: Resistant Genotypes of Hepatitis C, Drug-resistant Brucellosis, Cerebral Toxoplasmosis, Refractory Plague, Bovine Tuberculosis, Severe Leptospirosis, Resistant Anthrax, Drug-resistant Salmonella, Schistosomiasis, Drug-resistant Typhoid, Lymphatic Filariasis, Tropical Borreliosis Fever, Human Myiasis, Chagas Disease. ............................................................................................................. 7. Rare and Metabolic Syndromes (Rare & Metabolic Syndromes): Including: Erythromelalgia, Ehlers–Danlos Syndrome, Lysosomal Storage Disorders, Chronic Fatigue Syndrome (CFS/ME), Mitochondrial Disorders, Idiopathic Pulmonary Fibrosis (IPF), Usher Syndrome, Aicardi–Goutières Syndrome. ............................................................................................................. 8. End-Stage Cardiac, Renal and Metabolic Diseases (End-stage Organ Disorders): Including: End-stage Heart Failure, Terminal Renal Failure (without transplant), Type 1 Diabetes (Complete Cure), Severe Atherosclerosis. ............................................................................................................. This study demonstrates that the Hamzah Equation—through multidimensional integral structures, fractal derivatives, and immunological interactions within a reduced-entropy space—has the capacity not only to inhibit disease mechanisms but to restore the biological system to a regenerative state. It surpasses the confines of conventional medical science and achieves not merely treatment but enduring immunisation grounded in rigorous mathematical foundations. ............................................................................................................. AUTHOR: SEYED RASOUL JALALI. KUALA LUMPUR. MALAYSIA. ….……………………………………………………..
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-05-04
- DOI
- https://doi.org/10.5281/zenodo.15875295
- Primary Topic
- Biological Research and Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00